Accessibility Menu
Veracyte Stock Quote

Veracyte (NASDAQ: VCYT)

$34.84
(0.2%)
+0.09
Price as of October 23, 2025, 11:09 a.m. ET

KEY DATA POINTS

Current Price
$34.84
Daily Change
(0.2%) +$0.09
Day's Range
$34.53 - $35.01
Previous Close
$34.75
Open
$34.67
Beta
1.94
Volume
6,575
Average Volume
1,394,620
Market Cap
2.7B
Market Cap / Employee
$34.75M
52wk Range
$22.61 - $47.32
Revenue
-
Gross Margin
0.66%
Dividend Yield
N/A
EPS
$0.33
CAPs Rating
-
Industry
Biotechnology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Veracyte Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
VCYT+6.6%-6.94%-1.43%+162%
S&P+14.5%+93.32%+14.09%+280%

Veracyte Company Info

Veracyte Inc is engaged in the discovery, development, and commercialization of molecular cytology solutions that enable physicians to make more informed treatment decisions at an early stage in patient treatment.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$130.16M13.8%
Gross Profit$87.75M15.8%
Gross Margin67.42%1.2%
Market Cap$2.12B27.8%
Market Cap / Employee$2.57M0.0%
Employees8241.1%
Net Income-$0.98M-117.1%
EBITDA$19.80M89.6%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$219.50M-7.0%
Accounts Receivable$50.81M1.0%
Inventory2529.9%

Liabilities

Q2 2025YOY Change
Long Term Debt$44.23M226.4%
Short Term Debt$6.41M-10.7%

Ratios

Q2 2025YOY Change
Return On Assets2.04%6.6%
Return On Invested Capital-4.67%1.4%

Cash Flow

Q2 2025YOY Change
Free Cash Flow$32.32M20.6%
Operating Free Cash Flow$33.61M13.6%

Valuation

MetricQ4 2024Q1 2025Q2 2025YoY Change
Price to Earnings129.2070.6881.24-
Price to Book2.242.611.961.7719.64%
Price to Sales6.287.105.124.425.68%
Price to Tangible Book Value8.6510.067.036.20-7.04%
Price to Free Cash Flow TTM47.2949.5930.2625.24-39.44%
Enterprise Value to EBITDA133.66169.05338.5393.37-33.07%
Free Cash Flow Yield2.1%2.0%3.3%4.0%65.12%
Return on Equity-0.8%2.2%2.9%2.2%-145.87%
Total Debt$19.69M$50.74M$50.50M$50.65M144.22%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.